Tonix Pharmaceuticals Holding Corp

NASDAQ:TNXP   3:54:08 PM EDT
0.55
-0.01 (-2.09%)
: $0.57 +0.01 (+2.55%)
Earnings Announcements

Tonix Pharmaceuticals Reports Q3 Loss Per Share Of 0.09

Published: 11/09/2020 14:03 GMT
Tonix Pharmaceuticals Holding Corp (TNXP) - Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights.
Q3 Loss per Share $0.09.
Q3 Earnings per Share View $-0.11 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.